Figure 2.
Association between ALDH1A1 expression and disease-free survival in stage I lung adenocarcinomas, analyzed using Kaplan-Meier survival curves: Five-year disease-free survival rates were 94.3% and 82.1% in ALDH1A1 low- and high-expressers, respectively (Log-rank test, P = 0.119).